Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul V Fish

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 4, 2009
N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetrationFlorian Wakenhut, Gill A Allan, Paul V Fish, et al.
Journal of Medicinal Chemistry|June 27, 2007
Potent and selective nonpeptidic inhibitors of procollagen C-proteinasePaul V Fish, Gillian A Allan, Simon Bailey, et al.
Journal of Medicinal Chemistry|December 23, 2021
Virtual Screening Directly Identifies New Fragment-Sized Inhibitors of Carboxylesterase Notum with Nanomolar ActivityDavid Steadman, Benjamin N Atkinson, Yuguang Zhao, et al.
Medchemcomm|September 20, 2019
Discovery of 2-phenoxyacetamides as inhibitors of the Wnt-depalmitoleating enzyme NOTUM from an X-ray fragment screenBenjamin N Atkinson, David Steadman, Yuguang Zhao, et al.
Bioorganic & Medicinal Chemistry Letters|December 22, 2019
Scaffold-hopping identifies furano[2,3-d]pyrimidine amides as potent Notum inhibitorsBenjamin N Atkinson, David Steadman, William Mahy, et al.
Journal of Medicinal Chemistry|September 27, 2018
Antimalarial Lead-Optimization Studies on a 2,6-Imidazopyridine Series within a Constrained Chemical Space To Circumvent Atypical Dose-Response Curves against Multidrug Resistant Parasite StrainsClaire Le Manach, Tanya Paquet, Kathryn Wicht, et al.
Journal of Medicinal Chemistry|April 24, 2007
Selective urokinase-type plasminogen activator inhibitors. 4. 1-(7-sulfonamidoisoquinolinyl)guanidinesPaul V Fish, Christopher G Barber, David G Brown, et al.
Cancer Research|April 12, 2013
PFI-1, a highly selective protein interaction inhibitor, targeting BET BromodomainsSarah Picaud, David Da Costa, Angeliki Thanasopoulou, et al.
Journal of Medicinal Chemistry|July 18, 2017
Design of a Chemical Probe for the Bromodomain and Plant Homeodomain Finger-Containing (BRPF) Family of ProteinsNiall Igoe, Elliott D Bayle, Cynthia Tallant, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 2010
Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activityM Jonathan Fray, Paul V Fish, Gillian A Allan, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|August 4, 2009
N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetrationFlorian Wakenhut, Gill A Allan, Paul V Fish, et al.
Journal of Medicinal Chemistry|June 27, 2007
Potent and selective nonpeptidic inhibitors of procollagen C-proteinasePaul V Fish, Gillian A Allan, Simon Bailey, et al.
Journal of Medicinal Chemistry|December 23, 2021
Virtual Screening Directly Identifies New Fragment-Sized Inhibitors of Carboxylesterase Notum with Nanomolar ActivityDavid Steadman, Benjamin N Atkinson, Yuguang Zhao, et al.
Medchemcomm|September 20, 2019
Discovery of 2-phenoxyacetamides as inhibitors of the Wnt-depalmitoleating enzyme NOTUM from an X-ray fragment screenBenjamin N Atkinson, David Steadman, Yuguang Zhao, et al.
Bioorganic & Medicinal Chemistry Letters|December 22, 2019
Scaffold-hopping identifies furano[2,3-d]pyrimidine amides as potent Notum inhibitorsBenjamin N Atkinson, David Steadman, William Mahy, et al.
Journal of Medicinal Chemistry|September 27, 2018
Antimalarial Lead-Optimization Studies on a 2,6-Imidazopyridine Series within a Constrained Chemical Space To Circumvent Atypical Dose-Response Curves against Multidrug Resistant Parasite StrainsClaire Le Manach, Tanya Paquet, Kathryn Wicht, et al.
Journal of Medicinal Chemistry|April 24, 2007
Selective urokinase-type plasminogen activator inhibitors. 4. 1-(7-sulfonamidoisoquinolinyl)guanidinesPaul V Fish, Christopher G Barber, David G Brown, et al.
Cancer Research|April 12, 2013
PFI-1, a highly selective protein interaction inhibitor, targeting BET BromodomainsSarah Picaud, David Da Costa, Angeliki Thanasopoulou, et al.
Journal of Medicinal Chemistry|July 18, 2017
Design of a Chemical Probe for the Bromodomain and Plant Homeodomain Finger-Containing (BRPF) Family of ProteinsNiall Igoe, Elliott D Bayle, Cynthia Tallant, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 2010
Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activityM Jonathan Fray, Paul V Fish, Gillian A Allan, et al.
Pageof 6